Table of Content

Table of Contents
Table of Contents
1 Industry Overview
1.1 Pulmonary Hypertension Drugs Industry
Figure Pulmonary Hypertension Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Pulmonary Hypertension Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Pulmonary Hypertension Drugs
1.2.2 Downstream
Table Application Segment of Pulmonary Hypertension Drugs
Table Global Pulmonary Hypertension Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Pulmonary Hypertension Drugs Market by Type
3.1 By Type
3.1.1 Prostacyclin and prostacyclin analogs 
Table Major Company List of Prostacyclin and prostacyclin analogs 
3.1.2 Endothelin receptor antagonists (ERAs) 
Table Major Company List of Endothelin receptor antagonists (ERAs) 
3.1.3 Phosphodiesterase-5 (PDE-5) inhibitors 
Table Major Company List of Phosphodiesterase-5 (PDE-5) inhibitors 
3.1.4 Soluble guanylate cyclase (sGC) stimulators
Table Major Company List of Soluble guanylate cyclase (sGC) stimulators
3.2 Market Size
Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Type, in USD Million
Figure Global Pulmonary Hypertension Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Type, in Volume
Figure Global Pulmonary Hypertension Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Bayer  (Company Profile, Sales Data etc.)
4.1.1 Bayer  Profile
Table Bayer  Overview List
4.1.2 Bayer  Products & Services
4.1.3 Bayer  Business Operation Conditions
Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 GSK  (Company Profile, Sales Data etc.)
4.2.1 GSK  Profile
Table GSK  Overview List
4.2.2 GSK  Products & Services
4.2.3 GSK  Business Operation Conditions
Table Business Operation of GSK  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Arena  (Company Profile, Sales Data etc.)
4.3.1 Arena  Profile
Table Arena  Overview List
4.3.2 Arena  Products & Services
4.3.3 Arena  Business Operation Conditions
Table Business Operation of Arena  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Actelion  (Company Profile, Sales Data etc.)
4.4.1 Actelion  Profile
Table Actelion  Overview List
4.4.2 Actelion  Products & Services
4.4.3 Actelion  Business Operation Conditions
Table Business Operation of Actelion  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Pfizer  (Company Profile, Sales Data etc.)
4.5.1 Pfizer  Profile
Table Pfizer  Overview List
4.5.2 Pfizer  Products & Services
4.5.3 Pfizer  Business Operation Conditions
Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 United Therapeutics  (Company Profile, Sales Data etc.)
4.6.1 United Therapeutics  Profile
Table United Therapeutics  Overview List
4.6.2 United Therapeutics  Products & Services
4.6.3 United Therapeutics  Business Operation Conditions
Table Business Operation of United Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Gilead Sciences  (Company Profile, Sales Data etc.)
4.7.1 Gilead Sciences  Profile
Table Gilead Sciences  Overview List
4.7.2 Gilead Sciences  Products & Services
4.7.3 Gilead Sciences  Business Operation Conditions
Table Business Operation of Gilead Sciences  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Lung Biotechnology PBC (Company Profile, Sales Data etc.)
4.8.1 Lung Biotechnology PBC Profile
Table Lung Biotechnology PBC Overview List
4.8.2 Lung Biotechnology PBC Products & Services
4.8.3 Lung Biotechnology PBC Business Operation Conditions
Table Business Operation of Lung Biotechnology PBC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Pulmonary Hypertension Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Pulmonary Hypertension Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Pulmonary Hypertension Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Pulmonary Hypertension Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Pulmonary Hypertension Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Pulmonary Hypertension Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Pulmonary Hypertension Drugs Market Concentration, in 2020
Figure Europe Pulmonary Hypertension Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Pulmonary Hypertension Drugs MMarket Concentration, in 2020
Figure South America Pulmonary Hypertension Drugs Market Concentration, in 2020
Figure Middle East & Africa Pulmonary Hypertension Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Early-stage Drug Candidates (Phase I & Phase II)
Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2016-2020, in USD Million
Figure Pulmonary Hypertension Drugs Demand in Early-stage Drug Candidates (Phase I & Phase II), 2016-2020, in Volume
6.1.2 Demand in Late-stage Drug Candidates (Phase III & Registration Phase)
Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2016-2020, in USD Million
Figure Pulmonary Hypertension Drugs Demand in Late-stage Drug Candidates (Phase III & Registration Phase), 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Pulmonary Hypertension Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Pulmonary Hypertension Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Pulmonary Hypertension Drugs Market Share in 2026, by Application, in USD Million
Table Pulmonary Hypertension Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Pulmonary Hypertension Drugs Market Growth 2021-2026, by Application, in Volume
Table Pulmonary Hypertension Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Pulmonary Hypertension Drugs Production 2016-2020, by Region, in USD Million
Table Pulmonary Hypertension Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Region, in USD Million
Table Global Pulmonary Hypertension Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Region, in Volume
Table Global Pulmonary Hypertension Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Pulmonary Hypertension Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion

List of Figure

List of Table
List of Table
1. Table Upstream Segment of Pulmonary Hypertension Drugs
2. Table Application Segment of Pulmonary Hypertension Drugs
3. Table Global Pulmonary Hypertension Drugs Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Endothelin receptor antagonists (ERAs) 
5. Table Major Company List of Phosphodiesterase-5 (PDE-5) inhibitors 
6. Table Major Company List of Soluble guanylate cyclase (sGC) stimulators
7. Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Type, in USD Million
8. Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Type, in Volume
9. Table Global Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Type, in USD Million
10. Table Global Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Type, in Volume
11. Table Bayer  Overview List
12. Table Business Operation of Bayer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
13. Table GSK  Overview List
14. Table Business Operation of GSK  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Arena  Overview List
16. Table Business Operation of Arena  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Actelion  Overview List
18. Table Business Operation of Actelion  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table Pfizer  Overview List
20. Table Business Operation of Pfizer  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table United Therapeutics  Overview List
22. Table Business Operation of United Therapeutics  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Gilead Sciences  Overview List
24. Table Business Operation of Gilead Sciences  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
25. Table Lung Biotechnology PBC Overview List
26. Table Business Operation of Lung Biotechnology PBC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
27. Table Global Pulmonary Hypertension Drugs Sales Revenue 2016-2020, by Company, in USD Million
28. Table Global Pulmonary Hypertension Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
29. Table Global Pulmonary Hypertension Drugs Sales Volume 2016-2020, by Company, in Volume
30. Table Global Pulmonary Hypertension Drugs Sales Volume Share 2016-2020, by Company, in Volume
31. Table Regional Demand Comparison List
32. Table Major Application in Different Regions
33. Table Pulmonary Hypertension Drugs Demand Forecast 2021-2026, by Application, in USD Million
34. Table Pulmonary Hypertension Drugs Demand Forecast 2021-2026, by Application, in Volume
35. Table Pulmonary Hypertension Drugs Market Growth 2021-2026, by Application, in Volume
36. Table Pulmonary Hypertension Drugs Market Share in 2026, by Application, in Volume
37. Table Pulmonary Hypertension Drugs Production 2016-2020, by Region, in USD Million
38. Table Pulmonary Hypertension Drugs Production 2016-2020, by Region, in Volume
39. Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Region, in USD Million
40. Table Global Pulmonary Hypertension Drugs Market Share 2016-2020, by Region, in USD Million
41. Table Global Pulmonary Hypertension Drugs Market 2016-2020, by Region, in Volume
42. Table Global Pulmonary Hypertension Drugs Market Share 2016-2020, by Region, in Volume
43. Table North America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
44. Table North America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
45. Table Europe Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
46. Table Europe Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
47. Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
48. Table Asia-Pacific Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
49. Table South America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
50. Table South America Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
51. Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in USD Million
52. Table Middle East & Africa Pulmonary Hypertension Drugs Market Size 2016-2020, by Country, in Volume
53. Table Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Region, in USD Million
54. Table Pulmonary Hypertension Drugs Market Forecast 2021-2026, by Region, in Volume
55. Table Price Factors List